Page 5 of 5 · 111 questions tagged cardiovascular.
The specifics, since they change the answer: PIONEER-4 · ecnoglutide. I want to understand what this actually establishes, as opposed to what it is being used to…
What I have: STEP 4 · orforglipron. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The specifics, since they change the answer: SURPASS-2 · ecnoglutide. I want to understand what this actually establishes, as opposed to what it is being used to…
What I have: SOUL · orforglipron. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. Please show the division. I want to check my own against yours. I…
The particulars: SURMOUNT-2 · semaglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
I have three data points across nine months, which I hope is enough to see a trend. I would like the arithmetic checked rather than the conclusion asserted. I have…
What I have: STEP 3 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Setup, so nobody has to ask: STEP 1 · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I am working with: SURMOUNT-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
Details up front: STEP 3 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Conditions: REDEFINE-1 · liraglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
I have three data points across nine months, which I hope is enough to see a trend. I can do the algebra. I am not confident about the conversion factors. If there is…
Setup, so nobody has to ask: SUSTAIN-6 · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
What I am working with: SURPASS-2 · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…